11 Followers on Owler

Blade Therapeutics

Blade Therapeutics is a biopharmaceutical company that researches, discovers and commercializes drugs for the treatment of fibrotic diseases. Read more

Wendye Robbins's photo - President & CEO of Blade Therapeutics

President & CEO

Wendye Robbins

CEO Approval Rating

93/100

Founded:

2015

Status:

PrivateIndependent Company

BLADE THERAPEUTICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Galectin is Blade Therapeutics's #1 competitor. Galectin's headquarters is in Norcross, Georgia, and was founded in 2000. Galectin competes in the Pharmaceuticals industry. Galectin generates 100% of Blade Therapeutics's revenue.

Encycle Therapeutics is one of Blade Therapeutics's top rivals. Encycle Therapeutics was founded in Toronto, Ontario} in 2012. Encycle Therapeutics is in the Pharmaceuticals field. Compared to Blade Therapeutics, Encycle Therapeutics generates $4M more revenue.

Indalo Therapeutics is one of Blade Therapeutics's top competitors. Indalo Therapeutics is a Private company that was founded in 2014 in Cambridge, Massachusetts. Indalo Therapeutics operates in the Health Care Services industry. Compared to Blade Therapeutics, Indalo Therapeutics has 5 fewer employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Galecto a competitor of Blade Therapeutics?

Blade Therapeutics Acquisitions

No recent acquisitions found related to Blade Therapeutics

Blade Therapeutics Funding History

Since Blade Therapeutics was founded in 2015, it has participated in 3 rounds of funding. In total Blade Therapeutics has raised $83.1M. Blade Therapeutics' last funding round was on Nov 2018 for a total of $38.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Nov 2018
$38M
-
Series B
Oct 2017
$18M
Series B
Jun 2016
$27.1M

Since Blade Therapeutics was founded in 2015, it has participated in 3 rounds of funding. In total Blade Therapeutics has raised $83.1M. Blade Therapeutics' last funding round was on Nov 2018 for a total of $38.0M

Blade Therapeutics Investments

No recent investments found related to Blade Therapeutics

Blade Therapeutics News

August 13, 2020PharmaLeaders

Blade Therapeutics updates enrolment progress for Covid-19 pneumonia study of BLD-2660

Started in May 2020, BLADE-CONQUER (ClinicalTrials.gov NCT04334460) is a double-blind, placebo-contro... See more »
November 26, 2019BioPortfolio

Blade Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference

Blade Therapeutics a biopharmaceutical company advancing novel antifibrotic therapies today announced... See more »
November 14, 2019MarketScreener

to Present at the Stifel 2019 Healthcare Conference

(marketscreener.com) Blade Therapeutics, a biopharmaceutical company advancing novel anti-fibrotic th... See more »
October 22, 2019BioPortfolio

RAPT Therapeutics Strengthens Board with Addition of Veteran Biotechnology Executive Wendye Robbins M.D.

RAPT Therapeutics Inc. a clinicalstage immunologybased biopharmaceutical company developing oral smal... See more »
September 27, 2019Pharmabiz

Blade Therapeutics acquires ATXCo and its autotaxin inhibitor, PAT─409

Blade Therapeutics, a biopharmaceutical company advancing novel anti─fibrotic therapies, announced th... See more »
August 1, 2019BioPortfolio

Blade Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference

Blade Therapeutics a biopharmaceutical company advancing novel antifibrotic therapies today announced... See more »
July 31, 2019BioPortfolio

Blade Therapeutics Announces Publication of Preclinical Data Supporting Calpain 9 as a Promising Therapeutic Target for Fibrotic Disease

Findings validate the mechanism of action for the Companys lead asset BLD2660 Blade Therapeutics a bi... See more »

Blade Therapeutics Press Releases

Social Media

Blade Therapeutics Headquarters

442 Littlefield Avenue

South San Francisco, California94080

650-278-4291

Driving Directions »

Trending Companies

Blade Therapeutics Summary

ABOUT

Overview

Blade Therapeutics is a biopharmaceutical company that researches, discovers and commercializes drugs for the treatment of fibrotic diseases. Blade Therapeutics was founded in 2015. Blade Therapeutics' headquarters is located in South San Francisco, C...

CEO

Blade Therapeutics's President & CEO, Wendye Robbins, currently has an approval rating of 93%. Blade Therapeutics's primary competitors are Galectin, Encycle Therapeutics & Indalo Therapeutics.

Frequently Asked Questions about Blade Therapeutics

  1. When was Blade Therapeutics founded?

    Blade Therapeutics was founded in 2015
  2. Who is Blade Therapeutics's CEO?

    Blade Therapeutics's CEO is Wendye Robbins
  3. How much revenue does Blade Therapeutics generate?

    Blade Therapeutics generates $ < 1M in revenue
  4. How much funding does Blade Therapeutics have?

    Blade Therapeutics has historically raised $83.1M in funding
  1. Where is Blade Therapeutics's headquarters?

    Blade Therapeutics's headquarters is in South San Francisco California, USA
  2. How many employees does Blade Therapeutics have?

    Blade Therapeutics has 25 employees
  3. What sector does Blade Therapeutics operate in?

    Blade Therapeutics is in Health Care Technology
  4. Who are Blade Therapeutics's competitors?

    Blade Therapeutics's top competitors are Galectin, Encycle Therapeutics, Indalo Therapeutics